McKesson (MCK) closed at $705.45 in the latest trading session, marking a -3.06% move from the prior day.
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services lea.
![]() MCK 1 month ago | Other | €0.61 Per Share |
![]() MCK 4 months ago | Other | €0.61 Per Share |
![]() MCK 7 months ago | Other | €0.61 Per Share |
![]() MCK 10 months ago | Other | €0.61 Per Share |
![]() MCK 3 Jun 2024 | Other | €0.53 Per Share |
6 Aug 2025 (In 1 month) Date | | 8.2 Cons. EPS | - EPS |
5 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
8 May 2025 Date | | - Cons. EPS | - EPS |
5 May 2025 Date | | - Cons. EPS | - EPS |
5 Feb 2025 Date | | - Cons. EPS | - EPS |
![]() MCK 1 month ago | Other | €0.61 Per Share |
![]() MCK 4 months ago | Other | €0.61 Per Share |
![]() MCK 7 months ago | Other | €0.61 Per Share |
![]() MCK 10 months ago | Other | €0.61 Per Share |
![]() MCK 3 Jun 2024 | Other | €0.53 Per Share |
6 Aug 2025 (In 1 month) Date | | 8.2 Cons. EPS | - EPS |
5 Aug 2025 (In 1 month) Date | | - Cons. EPS | - EPS |
8 May 2025 Date | | - Cons. EPS | - EPS |
5 May 2025 Date | | - Cons. EPS | - EPS |
5 Feb 2025 Date | | - Cons. EPS | - EPS |
Medical - Distribution Industry | Healthcare Sector | Brian S. Tyler CEO | XDUS Exchange | US58155Q1031 ISIN |
US Country | 44,000 Employees | 3 Mar 2025 Last Dividend | 5 Jan 1998 Last Split | 15 Nov 1994 IPO Date |
McKesson Corporation stands as a prominent provider of healthcare services not only within the United States but also on an international platform. With its foundation laid in 1833, the company has excelled in extending its footprint across various segments of the healthcare industry, making it headquartered in Irving, Texas. Operating through four main segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International, McKesson strives to address the variegated needs of the healthcare realm. These segments collaborate to distribute pharmaceuticals, offer technological and clinical solutions, and ensure necessary medical supplies reach healthcare providers efficiently.
This segment is instrumental in distributing a vast array of pharmaceuticals, including branded, generic, specialty, biosimilar, and over-the-counter drugs. Furthermore, it caters to community-based oncology and other specialty practices by supplying practice management, technology, clinical support, and business solutions. Additionally, it encompasses services like consulting, outsourcing, technological offerings, and providing financial, operational, and clinical solutions targeted at pharmacies.
Under this banner, McKesson takes a significant step towards bridging the medication-related gaps between biopharma, life sciences partners, and patients by interlinking patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. The RxTS segment aims at rolling out innovative solutions to streamline the process of medication acquisition, ensuring the delivery of medicine that enriches patient health. Services rendered include prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support.
This segment ensures the streamlined distribution of medical and surgical supplies, logistics, and other pivotal services to various healthcare settings, encompassing physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. It represents McKesson's commitment to providing essential supplies and services that support the health ecosystem's backbone, thereby enabling healthcare providers to deliver quality care.
McKesson's International segment focuses on the distribution of pharmaceuticals and medical supplies, along with rendering services to a vast customer base, including wholesale, institutional, and retail channels across Europe and Canada. This segment showcases the company's dedication to extending its healthcare services and products to a global audience, ensuring an international footprint in healthcare distribution and services.